Last Updated 20 October 2021.
4 Vaccines Approved for Use in United Kingdom of Great Britain and Northern Ireland
-
Moderna
mRNA-1273- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 76 countries
31 trials in 2 countries
Approval Source: bbc.com
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 103 countries
37 trials in 2 countries
Approval Source: nytimes.com
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 75 countries
13 trials in 16 countries
Approval Source: bbc.com
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 124 countries
45 trials in 23 countries
Approval Source: astrazeneca.com
6 Vaccines in Clinical Trials in United Kingdom of Great Britain and Northern Ireland
-
Novavax
NVX-CoV2373- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
10 trials in 7 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 75 countries
13 trials in 16 countries
-
Oxford/AstraZeneca
AZD2816- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
2 trials in 2 countries
-
Valneva
VLA2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 2 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 124 countries
45 trials in 23 countries
-
Codagenix Inc
COVI-VAC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
1 Vaccines with Trials in United Kingdom of Great Britain and Northern Ireland are No Longer Progressing
-
Imperial
LNP-nCoVsaRNA- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country